Corteva, Inc. (CTVA) Stock Price, News, Analysis

NewEarnings release, scored · filed Jul 30, 2026Guidance raised · tone -10.9 vs prior release · 78 lines scoredSee the breakdown

Technical Score (1D)

BULLISH

News Sentiment

MIXED

On Oct 9, Corteva completed the spin‑off of its seed business into Vylor Inc., narrowing its focus to crop protection and digital agriculture. The separation reduced Corteva’s product mix and revenue base, while Vylor inherited the seed portfolio and its growth prospects. Legal scrutiny over PFAS‑related obligations emerged, raising uncertainty about liability allocation between the two companies. On the same day, Corteva’s shares rose 9.4 % in the week, reflecting renewed investor interest after the spin‑off and a sharpened focus on crop protection. Analysts linked the price increase to a growth upgrade tied to a strong product pipeline and earnings prospects, suggesting the shares were trading at a fair valuation for future dividend income. The move signals a strategic refocus but introduces regulatory and financial risks that could weigh on investor sentiment.

CTVA|Analyst Targets

LOW TARGET

$14 +1.9%

2 analysts

MEAN TARGET

$17 +28.7%

17 analysts

HIGH TARGET

$20 +49.3%

12 analysts

PRICE RANGE

$13.65 - $20.00

SB / B / H / S / SS

7/13/9/1/1

DAILYIQ EST.

$17.75 (+32.5%)

CTVA|Company Info

Sector

Basic Materials

Industry

Agricultural Inputs

Exchange

NYQ

Country

United States

Website

corteva.com

Symbol

CTVA

Description

Corteva, Inc. is a global agricultural company focused on providing farmers with innovative solutions for crop production. The company operates through two primary segments: Seed and Crop Protection. Its Seed segment develops and supplies advanced seed genetics and traits designed to optimize crop yields and enhance resistance to environmental challenges and pests. The Crop Protection segment offers a portfolio of herbicides, insecticides, and other products that protect crops from various threats, while also promoting plant health. Corteva's products and services are utilized across the agricultural input industry, with a global presence spanning North and South America, Europe, Asia Pacific, and Africa. The company, headquartered in Indianapolis, Indiana, was established in 2018.

CTVA|Insider Trading

Bought (1Y)

0 shares

Sold (1Y)

8,963 shares

$727K

KISSAM LUTHER C IVChief Executive Officer

J127,949 shares2026-10-01

TITUS BRIANSee Remarks

J14,393 shares2026-10-01

TITUS BRIANSee Remarks

J17,661 shares2026-10-01

TITUS BRIANSee Remarks

J14,772 shares2026-10-01

TITUS BRIANSee Remarks

J11,083 shares2026-10-01

CTVA|Fundamentals

Bullish

Overall: Bullish

✓Revenue growing year over year

✓Positive net margin

✓Positive operating cash flow

Net Margin

6.3%

Revenue CAGR

2.9%

Current Ratio

1.43x

Debt / Equity

0.10x

Return on Equity

4.5%

CTVA|Earnings Snapshot

Earnings Summary

Corteva, Inc. is a global agricultural company focused on crop protection and digital agriculture, operating through Seed and Crop Protection segments. The company’s recent strategic shift—spinning off its seed business into Vylor Inc.—has narrowed its product mix but sharpened its focus on the crop protection market, a sector that remains critical for global food security. In Q4 2024, Corteva reported EPS of $0.32 versus an estimate of $0.312, and revenue of $3.98 billion, modestly beating expectations. The following quarter, Q1 2025, saw EPS rise to $1.13 against an estimate of $0.881, with revenue climbing to $4.42 billion, indicating accelerating earnings and top‑line growth. Q2 2025 continued the upward trend with EPS of $2.20 versus $1.8789 expected, and revenue surging to $6.46 billion. However, Q3 2025 reported a negative EPS of $‑0.23, a decline from the prior quarter’s $2.20, and revenue data were not disclosed. In Q4 2025, EPS fell to $0.22 against an estimate of $1.17493, while revenue dropped to $3.91 billion from an estimate of $4.64 billion, reflecting a sharp reversal. Q1 2026 reversed the trend with EPS of $1.50 versus $1.18007 expected and revenue of $4.905 billion against an estimate of $4.637 billion, showing a rebound. Q2 2026 maintained strong earnings with EPS of $2.30 versus $2.23442 expected and revenue of $6.379 billion versus an estimate of $6.714 billion, suggesting a slight revenue shortfall but robust profitability. Historically, Corteva has delivered consistent EPS growth over the past four quarters, though revenue has fluctuated, especially following the spin‑off. The company has frequently beat analyst estimates in recent quarters, underscoring resilient earnings momentum despite revenue volatility. Recent news highlights the October 9 spin‑off and subsequent analyst upgrades, which have bolstered investor sentiment and positioned Corteva as a pure‑play crop protection firm.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q3'26	$0.09	-	-
Q2'26	$2.23	$2.30	+2.9%
Q1'26	$1.18	$1.50	+27.1%
Q4'25	$1.17	$0.22	-81.3%
Q3'25	$-0.47	$-0.23	+50.6%
Q2'25	$1.88	$2.20	+17.1%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q3'26	$2.7B	-	-
Q2'26	$6.7B	$6.4B	-5.0%
Q1'26	$4.6B	$4.9B	+5.8%
Q4'25	$4.6B	$3.9B	-15.8%
Q3'25	-	-	-
Q2'25	-	$6.5B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

CTVA|Monthly Returns

Market Data

CTVA Stock Snapshot

BULLISH78/100

$13.30−$0.11 (0.8%)

Market cap: 8.95B
P/E ratio: 8.9
Day range: $13.20 – $13.55
News sentiment: 50/100 · Neutral
Analyst target: $17.24 (+29.6%)
Consensus: Buy · 31 analysts

52-week range+13.3% off low · -85.4% from high

$11.74$90.97

Price $13.30 DailyIQ Est. $17.75

Momentum is working in CTVA's favour - it ranks in the upper part of DailyIQ's momentum universe. At this size, a single catalyst moves the stock further than it would a larger peer.

Sector Rotation

Is money rotating into or out of CTVA's sector?

Corteva, Inc. sits in the Materials sector, currently ranked 9th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank: #9 of 12
Sector state: Improving
Sector rotation score: 45

Options Market

What is the options market pricing for CTVA?

CallsPuts

For Corteva, Inc.'s nearest expiry (2026-10-16, 2 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.47), with at-the-money implied volatility around 76.6%. The options market is pricing roughly a ±5.3% move by that expiry — a range of about $12.63–$14.05.

Put/call ratio (2026-10-16): 0.47
ATM implied volatility: 76.6%
Total open interest: 7,749
Expected move by 2026-10-16: ±5.3% ($12.63–$14.05)

Analyst Rating Changes

Are analysts turning bullish or bearish on CTVA?

UBS most recently reiterated its rating on Corteva, Inc. to Neutral on Oct 12, 2026 with a price target of $15 (from $90). Over the last 90 days, coverage has run 2 upgrades against 0 downgrades, a net bullish lean.

Latest action: UBS — Neutral
90-day upgrades: 2
90-day downgrades: 0
Net rating momentum: +2

Date	Firm	Action	Rating	Price target
Oct 12, 2026	UBS	Maintained	Neutral	$90 → $15
Oct 7, 2026	Keybanc	Upgrade	Sector Weight → Overweight	$17
Oct 6, 2026	JP Morgan	Upgrade	Neutral → Overweight	$83 → $19
Sep 18, 2026	Argus Research	Reiterated	Buy	$91
Sep 17, 2026	Citigroup	Maintained	Neutral	$86 → $91
Sep 16, 2026	BMO Capital	Maintained	Outperform	$100 → $95
Sep 16, 2026	UBS	Maintained	Neutral	$85 → $90
Sep 16, 2026	RBC Capital	Reiterated	Outperform	$103
Sep 11, 2026	Keybanc	Initiated	Sector Weight	-
Aug 18, 2026	UBS	Maintained	Neutral	$89 → $85
Aug 3, 2026	UBS	Maintained	Neutral	$86 → $89
Aug 3, 2026	Citigroup	Maintained	Neutral	$85 → $86

Earnings Release, Scored

What did Corteva, Inc.'s latest earnings release say?

Filed Jul 30, 2026 · SEC Form 8-K, Exhibit 99

Guidance raised

Tone70.8/ 100-10.9 vs prior release

Hedging words0.51per 100 words-0.16 vs prior release

Tone, last 2 releases

Scale 50–87

Most important lines

1
1 News Release Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation • Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth • Crop Protection 1H demand for new products and focus on operational excellence helped offset competitive pricing dynamics • Full-year 2026 guidance3 increased to reflect strong first half performance, incremental benefits on controllable levers, and growth platforms • Corteva remains on-track to complete the planned separation, targeting October 1 Vylor spin-off date INDIANAPOLIS, Ind., July 30, 2026 – Corteva, Inc. (NYSE: CTVA) (“Corteva” or the “Company”) today reported financial results for the second quarter and six months ended June 30, 2026.
Guidance raisedNew this quarter
2
Given these results, and our confidence in the opportunities ahead, we are raising our full-year guidance.
Guidance raisedNew this quarter
3
As a result of these market dynamics and coupled with our strong first half execution, the Company increased full-year 2026 guidance3 with Operating EBITDA1 expected to be $4.1 billion to $4.3 billion, growth of 9% at the mid-point.
Guidance raised

Peers & ETF holders

CTVA peers & ETF holders

Agricultural InputsMarket cap · today

CTVAYou're here$8.9B-0.82%
CFCF Industries Holdings, Inc.$17.5B+0.03%
MOSThe Mosaic Company$6.1B+1.10%
FMCFMC Corporation$1.3B+0.74%

Top ETF holdersWeight

News Sentiment Analysis

Sentiment gathered from recent headlines

50/100

Strong NegativeNeutralStrong Positive

MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Corteva (CTVA) announced the spin‑off of Vylor (VYLR), shifting its focus to crop chemicals. UBS analysts highlighted that the move could provide growth opportunities but also introduces new risks, such as increased competition and market volatility. The company’s guidance remains cautious, reflecting uncertainty about the timing and scale of the benefits from the spin‑off.

What did this article say?

On October 1, 2026, 15 states and one sovereign filed litigation challenging Corteva's separation. Corteva stated that the court order does not affect the completion of the Vylor separation and is not in effect pending resolution of the motion. The company emphasized that the separation process remains on schedule. This clarification indicates no immediate operational impact.

What did this article say?

Corteva (CTVA) was delisted from several major equity indices, including the S&P 500 and FTSE All‑World, when its spin‑off unit Vylor (VYLR) entered those indices. The removal coincided with Vylor completing corporate charter amendments to establish it as an independent entity. The index change signals a shift in market perception and may affect institutional exposure to Corteva. The move does not indicate a fundamental decline in Corteva’s business fundamentals, but it could reduce passive investment flows. Overall, the event represents a modest negative headwind for Corteva’s market visibility.

What did this article say?

Corteva’s shares climbed 9.4% last week, prompting analysis of whether the current price reflects its dividend potential. The company’s focus on crop protection after spinning off its seed business into Vylor underpins expectations of earnings growth from a robust product pipeline. Analysts weigh the dividend discount model against a 15.7x P/E valuation, debating whether the $13.75 share price aligns with intrinsic value. The growth upgrade suggests optimism about future profitability, but the fair‑value assessment remains contested.

What did this article say?

Corteva (CTVA) delivered a 3.56% annualized return over the past five years, exceeding the broader market by roughly 15.98% per year. The company’s market capitalization stands at $9.23 billion. The performance highlights the firm’s consistent growth and resilience amid agricultural commodity volatility. No new catalysts or guidance changes were disclosed, indicating the result reflects historical performance rather than a forward‑looking shift.

What did this article say?

Corteva completed the spin‑off of its seed business into Vylor Inc., leaving the company to concentrate on crop protection and digital agriculture. The separation reduces Corteva’s product mix and revenue base, while Vylor inherits the seed portfolio and associated growth prospects. Legal scrutiny over PFAS‑related obligations has emerged, raising uncertainty about liability allocation between the two entities. The move signals a strategic refocus but introduces regulatory and financial risks that could weigh on investor sentiment.

What did this article say?

Analysts highlighted Corteva’s projected 3% annualized top‑line growth for FY26‑29, surpassing the broader crop protection sector. The company’s margin outlook was deemed constructive, supporting a positive earnings trajectory. Consequently, the analyst issued a buy recommendation, signaling confidence in Corteva’s growth prospects.

What did this article say?

Jim Cramer discussed Corteva's breakup during an October 2 episode of Mad Money. He expressed confidence in building a position in Vylor Inc., the seed business spun off from Corteva, citing its scarcity value. Cramer remained cautious about Corteva's crop‑protection operations, noting potential challenges to growth. The commentary suggested a positive outlook for Vylor while leaving Corteva's crop‑protection prospects uncertain.

What did this article say?

Corteva Inc. (CTVA) reached a new all‑time high after analysts highlighted the company’s seed business spinoff as a growth catalyst. The stock rally was driven by positive commentary from rating agencies and a broader market rebound in the agriculture sector. The move reflects a confirmed, material upside for the company, as the spinoff is expected to unlock value and improve earnings prospects. The rally also helped lift investor sentiment toward the broader agribusiness industry. Overall, the event represents a significant positive development for Corteva’s valuation and outlook.

What did this article say?

On October 7, KeyBanc Capital Markets upgraded Corteva (CTVA) to overweight, citing a positive outlook for the company’s crop‑protection business. The brokerage raised its price target to $17 and highlighted the company’s $11 billion pipeline as a key driver. The upgrade followed Corteva’s recent spin‑off of its seed and genetics unit, positioning it as a pure‑play crop protection firm. Investors reacted with a 3.6% rise in afternoon trading, boosting the stock’s year‑to‑date gain to 43%. The move reflects confidence in Corteva’s ability to navigate post‑spin volatility and capitalize on an improving agricultural cycle.

Technical Analysis

Real-time indicators across multiple timeframes

BULLISH

Momentum rank against about 1,000 stocks and ETFs for this timeframe.

Unlock full technicals

Create a free account to access more indicators and deeper timeframe data.

Institutional & Hedge Fund Ownership

25 tracked managers · $27.23B combined position · 13 adding, 12 trimming, 0 unchanged (latest 13F filings)

Manager	Trend	Shares Held	% of Co.	Position Value	Filed
Vanguard Group Inc	▲ Buy	80,536,951	12.01%	$5.40B	2026-01-29
BlackRock, Inc.	▼ Sell	53,845,550	8.03%	$4.56B	2026-08-07
Capital World Investors	▲ Buy	42,923,729	6.40%	$3.64B	2026-08-12
FMR LLC (Fidelity)	▲ Buy	41,072,288	6.13%	$3.48B	2026-08-13
Geode Capital Management, LLC	▲ Buy	18,899,903	2.82%	$1.59B	2026-08-12
Harris Associates L P	▼ Sell	16,333,110	2.44%	$1.38B	2026-08-14
Northern Trust Corp	▼ Sell	12,066,415	1.80%	$1.02B	2026-08-13
Invesco Ltd.	▼ Sell	9,526,145	1.42%	$806.77M	2026-08-14
Morgan Stanley	▼ Sell	7,993,002	1.19%	$676.93M	2026-08-13
Wellington Management Group LLP	▲ Buy	7,612,704	1.14%	$644.72M	2026-08-14
Janus Henderson Group plc	▼ Sell	7,254,186	1.08%	$607.25M	2026-05-18
Goldman Sachs Group Inc	▲ Buy	7,111,959	1.06%	$602.31M	2026-08-14
JPMorgan Chase & Co	▲ Buy	6,423,177	0.96%	$535.50M	2026-08-12
Bank of America Corp	▲ Buy	5,725,909	0.85%	$484.93M	2026-08-14
Norges Bank	▼ Sell	5,496,133	0.82%	$465.47M	2026-08-12
AllianceBernstein L.P.	▼ Sell	4,439,611	0.66%	$371.64M	2026-08-14
AQR Capital Management LLC	▼ Sell	2,121,405	0.32%	$177.22M	2026-08-14
Balyasny Asset Management L.P.	▲ Buy	1,804,482	0.27%	$152.82M	2026-08-14
Citigroup Inc	▲ Buy	1,448,712	0.22%	$122.69M	2026-08-03
Millennium Management LLC	▲ Buy	1,310,524	0.20%	$110.99M	2026-08-14
Neuberger Berman Group LLC	▼ Sell	1,250,408	0.19%	$105.90M	2026-08-13
Wells Fargo & Company	▼ Sell	1,200,805	0.18%	$101.70M	2026-08-14
Citadel Advisors LLC	▲ Buy	865,225	0.13%	$73.28M	2026-09-02
Adage Capital Partners GP, L.L.C.	▼ Sell	756,037	0.11%	$64.03M	2026-08-14
Gotham Asset Management, LLC	▲ Buy	590,689	0.09%	$50.03M	2026-08-14

Q2 2026 flow:25.18M sh bought ($2.13B)13.25M sh sold ($1.12B)net +11.93M sh (+$1.01B)

Congressional Trading Activity

4 disclosed trades · ~$56.5K est. traded value · 1 buys, 3 sells

Member	Chamber	State	Type	Amount	Traded	Filed
Gilbert Cisneros	House	CA31	▼ Sell	$1K - $15K	2026-09-17	2026-10-12
Gary Peters	Senate	MI	▼ Sell	$15K - $50K	2026-04-23	2026-05-11
Alan Armstrong	Senate	OK	▲ Buy	$1K - $15K	2026-03-27	2026-07-21
Tommy Tuberville	Senate	AL	▼ Sell	$1K - $15K	2024-10-29	2026-08-05